The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20070602: American Securities Partners IV, L.P.; NEP, Inc.
20070600: Cisco Systems, Inc.; IronPort Systems, Inc.
20070594: QBE Insurance Group Limited; HDI Haftpflichtverband der Deutschen Industrie VaG
20070574: On Assignment, Inc.; Oxford Global Resources, Inc.
20070522: Wintergames Holdings SARL; Oak Hill Capital Partners, L.P.
20070377: Northrop Grumman Corporation; Essex Corporation
Leegin Creative Leather Products, Inc. v. PSKS, Inc. d/b/a Kay's Kloset ... Kay's Shoes
Credit Suisse Securities (USA) LLC v. Billing
Revised Jurisdictional Thresholds for Section 7A of the Clayton Act
Revised Jurisdictional Thresholds for Section 8 of the Clayton Act
Johnson & Johnson and Pfizer Inc., In the Matter of
The consent order settles charges that Johnson & Johnson’s (J&J) proposed $16.6 billion acquisition of Pfizer Inc.’s (Pfizer) Consumer Healthcare business would likely reduce competition in the U.S. markets for over-the-counter (OTC) H-2 blockers used to prevent and relieve heartburn, OTC hydrocortisone anti-itch products, OTC night-time sleep aids, and OTC diaper rash treatments. In settling the Commission’s charges, the companies have agreed to sell Pfizer’s Zantac H-2 blocker business to Boehringer Ingelheim Pharmaceuticals Inc. (Boehringer), and Pfizer’s Cortizone hydrocortisone anti-itch business, Pfizer’s Unisom night-time sleep aid business, and J&J’s Balmex diaper rash treatment business to Chattem, Inc.